Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis

References

• Bernareggi A. (1998) Clinical pharmacokinetics of nimesulide. Clinical Pharmacokinetics, 35, 247–274.
   PubMed Web of Science ®Google Scholar
• Brown N.L., Alvi S.A., Elder M.G., Bennett P.R. and Sullivan M.H.F. (1998) The regulation of prostaglandin production in intact fetal membranes by interleukin-1 and its receptor antagonist. Journal of Endocrinology, 159, 519–526.
   Google Scholar
• Ceppi-Monti N., Gazzaniga A., Giansello V., Stroppolo E. and Lodola E. (1992) Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittel-forschung, 42, 556–559.
   PubMed Web of Science ®Google Scholar
• Challis J.R., Lye S.J. and Gibb W. (1997) Prostaglandins and parturition. Annals of the New York Academy of Science, 828, 254–267.
   Google Scholar
• Goldstein H. (1998a) Multilevel Statistical Models (Internet edition), 2nd edn. London, Kendall's Library of Statistics 3.
   Google Scholar
• Goldstein H.R.J.P. (1998b) A user's guide to MLwiN. London, Institute of Education.
   Google Scholar
• Hebisch G., Grauaug A.A., Neumaier-Wagner P.M., Stallmach T., Huch A. and Huch R. (2001) The relationship between cervical dilatation, interleukin-6 and interleukin-8 during term labor. Acta Obstetricia et Gynecologica Scandinavica, 80, 840–848.
   PubMed Web of Science ®Google Scholar
• Helleberg L. (1981) Clincial pharmacokinetics of indo-methacin. Clinical Pharmacokinetics, 6, 245–258.
   PubMed Web of Science ®Google Scholar
• Hendricks S.K., Smith J.R., Moore D.E. and Brown Z.A. (1990) Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour. British Journal of Obstetrics and Gynaecology, 97, 312–316.
   PubMedGoogle Scholar
• Hirst J.J., Teixeira F.J., Zakar T. and Olson D.M. (1995) Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. Journal of Clinical Endocrinology and Metabolism, 80, 517–523.
   PubMed Web of Science ®Google Scholar
• Kelly R.W. (1994) Pregnancy maintanance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocrine Reviews, 15, 684–706.
   PubMed Web of Science ®Google Scholar
• Kelly R.W. (1996) Inflammatory mediators and parturition. Reviews in Reproduction, 1, 89–96.
   PubMedGoogle Scholar
• Khan H., Ishihara O., Sullivan M.H.F. and Elder M.G. (1992) Changes in decidual stromal cell function associated with labour. British Journal of Obstetrics and Gynaecology, 99, 10–12.
   Google Scholar
• Kirshon B., Moise K.J., Wasserstrum N., Ou C.N. and Huhta J.C. (1988) Influence of short-term indomethacin on fetal urine output. Obstetrics and Gynecology, 72, 51–53.
   PubMed Web of Science ®Google Scholar
• Knock GA. and Aaronson P.I. (1999) Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes. British Journal of Pharma-cology, 127, 1470–1478.
   Google Scholar
• Kramer M.S., Platt R., Yang H., Joseph KS., Wen S.W., Morin L. and Usher R.H. (1998) Secular trends in preterm birth: a hospital-based cohort study. Journal of the American Medical Association, 280, 1849–1854.
   PubMed Web of Science ®Google Scholar
• Lewis R.B. and Schulman J.D. (1973) Influence of acetyl-salicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet, 2, 1159–1161.
   PubMed Web of Science ®Google Scholar
• Macones G.A. and Robinson C.A. (1997) Is there justification for using indomethacin in preterm labor? An analysis of risks and benefits. American Journal of Obstetrics and Gynecology, 177, 819–824.
   PubMed Web of Science ®Google Scholar
• Moise K.J., Huhta J.C., Sharif D.S., Ou C.N., Kirshon B., Wasserstrum N. and Cano L. (1988) Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. New England Journal of Medicine, 319, 327–331.
   PubMed Web of Science ®Google Scholar
• Ojala R., Ikonen S. and Tammela O. (2000) Perinatal indo-methacin treatment and neonatal complications in preterm infants. European Journal of Pediatrics, 159, 153–155.
   PubMed Web of Science ®Google Scholar
• Peruzzi L., Gianoglio B., Porcellini M.G. and Coppo R. (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase type-1 selective inhibitor nimesulide as tocolytic. Lancet, 354, 1615.
   PubMed Web of Science ®Google Scholar
• Rajasingam D., Bennett P.R., Alvi S.A., Elder M.G. and Sullivan M.H.F. (1998) Stimulation of prostaglandin pro-duction from intact human fetal membranes by bacteria and bacterial products. Placenta, 19, 301–306.
   PubMed Web of Science ®Google Scholar
• Riendeau D., Percival M.D., Boyce S., Charleson S., Cromlish W., Ethier D., Evans J., Falgueyret J.P., Ford-Hutchinson A.W., Gordon R., Greig G., Gresser M., Guay J., Kargman S., Leger S., Mancini J.A., O'Neill G., Ouellet M., Rodger 1.W., Therien M., Wang Z., Webb J.K., Wong E. and Chan C.C. (1997) Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. British Journal of Pharmacology, 121, 105–117.
   Google Scholar
• Romero R., Durum S., Dinarello C.A., Oyarzun E., Hobbins J.C. and Mitchell M.D. (1989) Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglan-dins, 37, 13–22.
   PubMed Web of Science ®Google Scholar
• Romero R., Ceska M., Avila C., Mazor M., Behnke E. and Lindley I. (1991) Neutrophil attractant/activating peptide-1 /interleukin-8 in term and preterm parturition. American Journal of Obstetrics and Gynecology, 165, 813–820.
   PubMed Web of Science ®Google Scholar
• Romero R., Mazor M., Brandt F., Sepulveda W., Avila C., Cotton C.B. and Dinarello C.A. (1992) Interleukin-1 alpha and interleukin-lbeta in preterm and term human parturition. American Journal of Reproductive Immunology, 27, 117–123.
   PubMed Web of Science ®Google Scholar
• Royston P. and Altman D.G. (1994) Regression using frac-tional polynomials of continuous covariates: parsimonious parametric modelling. Applied Statistics, 43, 429–467.
   Web of Science ®Google Scholar
• Rumack CM., Guggenheim M.A., Rumack B.H., Peterson R.G., Johnson M.L. and Braithwaite W.R. (1981) Neonatal intracranial hemorrhage and maternal use of aspirin. Obstetrics and Gynecology, 58 (supplement 5), 52S–56S.
   Web of Science ®Google Scholar
• Sawdy R.J. and Bennett P.R. (1999) Recent advances in the therapeutic management of preterm labour. Current Opinion in Obstetrics and Gynecology, 11, 131–139.
   PubMedGoogle Scholar
• Sawdy R., Slater D., Fisk N., Edmonds D.K. and Bennett P. (1997) Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet, 350, 265–266.
   PubMed Web of Science ®Google Scholar
• Sawdy R., Knock GA., Bennett P.R., Poston L. and Aaronson P.I. (1998) Effect of nimesulide and indomethacin on contractility and the Ca2± channel current in myometrial smooth muscle from pregnant women. British Journal of Pharmacology, 125, 1212–1217.
   PubMed Web of Science ®Google Scholar
• Sawdy R.J., Slater D.M., Dennes W.J., Sullivan M.H.F. and Bennett P.R. (2000) The roles of the cyclo-oxygenases types one and two in prostaglandin synthesis in human fetal membranes at term. Placenta, 21, 54–57.
   PubMed Web of Science ®Google Scholar
• Slater D., Berger L., Newton R., Moore G. and Bennett P. (1994) The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochemical and Biophysical Research Communications, 198, 304–308.
   PubMed Web of Science ®Google Scholar
• Slater D.M., Berger L.C., Newton R., Moore G.E. and Bennett P.R. (1995) Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. American Journal of Obstetrics and Gynecology, 172, 77–82.
   PubMed Web of Science ®Google Scholar
• Slater D., Dennes W., Sawdy R., Allport V. and Bennett P. (1999) Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. Journal of Molecular Endocrinology, 22, 125–130.
   PubMed Web of Science ®Google Scholar
• Souter D., Harding J., McCowan L., O'Donnell C., McLeay E. and Baxendale H. (1998) Antenatal indomethacin—adverse fetal effects confirmed. Australian and New Zealand Journal of Obstetrics and Gynaecology, 38, 11–16.
   PubMed Web of Science ®Google Scholar
• Turck D., Busch U., Heinzel G. and Narjes H. (1997) Clinical pharmacokinetics of meloxicam. Arzneimittelforschung, 47, 253–258.
   PubMed Web of Science ®Google Scholar
• Vane J.R., Bakhle Y.S. and Botting R.M. (1998) Cyclooxygenases 1 and 2. Annual Review in Pharmacology and Toxicology, 38, 97–120.
   Google Scholar
• Vince G.S., Starkey P.M., Jackson MC., Sargent I.L. and Redman C.W. (1990) Flow cytometric characterisation of cell populations in human pregnancy decidua and isolation of decidual macrophages. Journal of Immunological Methods, 132, 181–189.
   PubMed Web of Science ®Google Scholar
• Warner T.D., Giuliano F., Vojnovic I., Bukusa A., Mitchell J.A. and Vane J.R. (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are asso-ciated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences USA, 96, 7563–7568.
   PubMed Web of Science ®Google Scholar